NCT06020482 Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
| NCT ID | NCT06020482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | General University Hospital, Prague |
| Condition | Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-04-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of the project is to analyse gene expression in individual types of ectopic endometrium (ovarian endometriosis, peritoneal endometriosis, deep infiltrating endometriosis) and compare it with gene expression in eutopic endometrium. The analysis focuses on the identification of genes with significantly increased expression in each type of ectopic endometrium and comparison of their expression with the degree of disease, ovarian reserve and clinical manifestations of the disease (pain, infertility).
Eligibility Criteria
Inclusion Criteria: * women (18-45 years) * signed informed consent with the study * absence of hormonal treatment 3 months before the planned procedure Inclusion criteria for group A: \- laparoscopically and histologically confirmed endometriosis dg. Inclusion criteria for group B: * patients without endometriosis * patients who are undergoing an elective laparoscopic or hysteroscopic procedure in our department for another benign indication * patients with excluded malignant disease Exclusion Criteria: * absence of informed consent * patients who do not meet the inclusion criteria during surgery * patient younger than 18 years of age or older than 45 years of age
Frequently Asked Questions
Who can join the NCT06020482 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06020482 currently recruiting?
Yes, NCT06020482 is actively recruiting participants. Visit ClinicalTrials.gov or contact General University Hospital, Prague to inquire about joining.
Where is the NCT06020482 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06020482 clinical trial?
NCT06020482 is sponsored by General University Hospital, Prague. The trial plans to enroll 120 participants.